Detailed Information on Publication Record
2017
METABOLIC RATIOS OF LANSOPRAZOLE TO 5-HYDROXYLANSOPRAZOLE AND LANSOPRAZOLE TO LANSOPRAZOLE SULFONE FOR PREDICTION OF CYP2C19 AND CYP3A4 METABOLIC ACTIVITY
JUŘICA, Jan, Katarína KOSTOLANSKÁ, Ondřej PEŠ, Ota HLINOMAZ, Jan MÁCHAL et. al.Basic information
Original name
METABOLIC RATIOS OF LANSOPRAZOLE TO 5-HYDROXYLANSOPRAZOLE AND LANSOPRAZOLE TO LANSOPRAZOLE SULFONE FOR PREDICTION OF CYP2C19 AND CYP3A4 METABOLIC ACTIVITY
Name in Czech
Metabolický poměr lansoprazolu a 5-hydroxylansoprazolu a lansoprazol sulfonu pro predikci metabolické aktivity CYP2C19 a CYP3A4
Name (in English)
METABOLIC RATIOS OF LANSOPRAZOLE TO 5-HYDROXYLANSOPRAZOLE AND LANSOPRAZOLE TO LANSOPRAZOLE SULFONE FOR PREDICTION OF CYP2C19 AND CYP3A4 METABOLIC ACTIVITY
Authors
Edition
2017
Other information
Language
Czech
Type of outcome
Konferenční abstrakt
Field of Study
30104 Pharmacology and pharmacy
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
Keywords (in Czech)
lansoprazol; CYP2C19; CYP3A4
Keywords in English
lansoprazole; CYP2C19; CYP3A4
Změněno: 21/12/2017 20:39, doc. PharmDr. Jan Juřica, Ph.D.
V originále
lansoprazol as a probe drug of human CYP2C19, CYP3A4 metabolic activity in clinical settings
In English
lansoprazol as a probe drug of human CYP2C19, CYP3A4 metabolic activity in clinical settings
Links
GA16-06106S, research and development project |
| ||
MUNI/A/1063/2016, interní kód MU |
|